Anti-HERV-K antibodies were detected in patients with ovarian cancer, but not in normal female controls, documenting that HERV Env proteins, especially those expressed on the cell surface, may serve as novel tumor targets for detection, diagnosis, and immunotherapy of ovarian cancer (Wang-Johanning et al., 2007). Here, ERVW-1 is linked to ovarian cancer.